Recro Pharma, Inc. Files SEC Form S-3 Registration Statement

Recro Pharma, Inc. has recently filed a registration statement with the U.S. Securities and Exchange Commission (SEC) as part of its growth and expansion plans. The company, which specializes in the development and sale of pharmaceutical preparations, submitted a simplified registration form (Form S-3) on August 28, 2015. This filing marks an important milestone for Recro Pharma, Inc., a public company with a strong presence in the pharmaceutical industry. According to the SEC filing, the company has been required to report under the '34 Act for a minimum of twelve months and has met the timely filing requirements set forth under Form S-2.

Key Takeaways:

• Recro Pharma, Inc. (company code 2834) filed a registration statement with the SEC using Form S-3 on August 28, 2015.
• The company's SIC code for Pharmaceutical Preparations indicates its primary business activity.
• The SEC filing involves the submission of two documents, with the file number being 0001193125-15-306707.
• The company's contact information is 490 LAPP ROAD, MALVERN PA 19355, with a phone number of (484) 395-2400.
• Form S-3 is a simplified registration form for publicly-traded companies that have met specific eligibility criteria.
• Recro Pharma, Inc. has previously filed with the SEC under the '34 Act for at least twelve months and has met the timely filing requirements.

Statistics:

• Form S-3 filing date: August 28, 2015
• SEC filing number: 0001193125-15-306707
• SIC code for Recro Pharma, Inc.: 2834 (Pharmaceutical Preparations)
• Number of documents submitted: 2
• Phone number mentioned in the filing: (484) 395-2400
• Company address: 490 LAPP ROAD, MALVERN PA 19355

Sources:

• NewsRx (2015, Sep 14). Recro Pharma, Inc. Files SEC Form S-3 Registration Statement. Pharma Business Week